|
Market Closed -
Other stock markets
|
After hours 18:41:00 | |||
| 57.46 EUR | +1.27% |
|
57.54 | +0.14% |
| Capitalization | 10.05B 11.7B 9.4B 8.78B 16.2B 1,052B 17.62B 109B 42.46B 499B 43.91B 42.98B 1,830B | P/E ratio 2025 * |
22.3x | P/E ratio 2026 * | 18.7x |
|---|---|---|---|---|---|
| Enterprise value | 13.75B 16.02B 12.86B 12.01B 22.17B 1,440B 24.12B 149B 58.1B 682B 60.1B 58.83B 2,504B | EV / Sales 2025 * |
1.88x | EV / Sales 2026 * | 1.75x |
| Free-Float |
66.44% | Yield 2025 * |
1.12% | Yield 2026 * | 1.23% |
Last Transcript: Eurofins Scientific SE
| 1 day | +1.27% | ||
| 1 week | -1.91% | ||
| Current month | -2.01% | ||
| 1 month | -0.93% | ||
| 3 months | -8.71% | ||
| 6 months | -2.31% | ||
| Current year | +16.53% |
| 1 week | 56.34 |  | 59.26 |
| 1 month | 54.86 | | 60.42 |
| Current year | 45.56 | | 69.4 |
| 1 year | 45.56 | | 69.4 |
| 3 years | 39.47 | | 72.12 |
| 5 years | 39.47 | | 127.68 |
| 10 years | 27.12 | | 127.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 62 | 31/12/1986 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 31/12/2014 |
Christian Wurst
PRN | Corporate Officer/Principal | - | 30/09/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CHM | Chairman | 62 | 31/12/1986 |
Yves-Loïc Martin
BRD | Director/Board Member | 59 | 31/12/2014 |
Valérie Hanote
BRD | Director/Board Member | 59 | 31/12/1989 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0.47% | 26 M€ | +11.19% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.27% | -1.91% | +20.34% | -13.54% | 11.69B | |
| -0.70% | -2.85% | +2.79% | +16.06% | 47.19B | |
| +1.19% | -2.84% | +8.65% | +3.58% | 37.14B | |
| +0.06% | -5.61% | +70.09% | +56.10% | 35.27B | |
| -0.85% | +0.81% | +15.81% | +16.84% | 27.89B | |
| +1.45% | +1.04% | +66.00% | +229.83% | 15.04B | |
| +1.91% | -3.75% | +62.26% | +162.59% | 15.33B | |
| +0.91% | -2.46% | -15.18% | -7.05% | 13.84B | |
| +0.52% | +1.83% | +69.51% | - | 13.5B | |
| -0.15% | -3.68% | +106.04% | +106.04% | 12.77B | |
| Average | +0.55% | -1.67% | +40.63% | +63.38% | 22.97B | |
| Weighted average by Cap. | +0.26% | -1.87% | +33.24% | +48.05% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 7.33B 8.53B 6.85B 6.4B 11.81B 767B 12.85B 79.44B 30.95B 364B 32.02B 31.34B 1,334B | 7.74B 9.02B 7.24B 6.76B 12.48B 810B 13.58B 83.95B 32.71B 384B 33.84B 33.12B 1,410B |
| Net income | 475M 553M 444M 415M 765M 49.7B 833M 5.15B 2.01B 23.56B 2.07B 2.03B 86.45B | 571M 665M 534M 499M 920M 59.74B 1B 6.19B 2.41B 28.32B 2.49B 2.44B 104B |
| Net Debt | 3.7B 4.31B 3.46B 3.24B 5.97B 388B 6.5B 40.16B 15.65B 184B 16.19B 15.84B 674B | 3.49B 4.06B 3.26B 3.05B 5.62B 365B 6.12B 37.81B 14.73B 173B 15.24B 14.91B 635B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/12/25 | 57.46 € | +1.27% | 251,284 |
| 09/12/25 | 56.74 € | -1.42% | 234,966 |
| 08/12/25 | 57.56 € | -2.14% | 322,194 |
| 05/12/25 | 58.82 € | -0.37% | 253,533 |
| 04/12/25 | 59.04 € | +0.79% | 308,381 |
Real-time Euronext Paris, December 10, 2025 at 04:55 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ERF Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition